Alprazolam Dosing Adjustments for Elderly, Hepatically Impaired, and Severely Ill Patients

Recommended Starting Dose

• Elderly, patients with hepatic impairment, or those with debilitating disease should begin alprazolam at 0.25 mg administered two to three times daily to reduce the risk of excessive sedation and other benzodiazepine‑related adverse effects. 1

Rationale for Lower Starting Dose

• In older adults, increased sensitivity to benzodiazepines warrants a reduced initial dose, because age‑related pharmacodynamic changes heighten the likelihood of cognitive impairment, falls, and respiratory depression. The NCCN guideline emphasizes this precaution. 2

Clinical Pitfalls to Avoid (Elderly & Hepatically Impaired)

• Do not apply the standard adult starting dose (0.25–0.5 mg three times daily) to elderly or hepatically impaired patients; using the lower 0.25 mg two‑to‑three‑times‑daily regimen is specifically recommended to mitigate heightened drug sensitivity. 3

• Avoid rapid dose escalation in these populations; titration intervals of at least 3–4 days are advised to allow full pharmacodynamic expression and to monitor tolerability. (Guideline recommendation; citation included in the same NCCN sources.) 1

• If adverse effects appear at the recommended low starting dose, further dose reduction should be considered to maintain safety while achieving therapeutic benefit. (Guideline recommendation; citation included.) 2